Nanoplasmas Private Company (PC) is a high-tech, innovation-driven, spin-out of NCSR Demokritos, the largest multidisciplinary research center in Greece. After more than 10 years of EU funded research and innovation protected by patents (presently transferred to Nanoplasmas from the Research center), the shareholders of Nanoplasmas have pioneered the “plasma nanotechnology for the fabrication of novel diagnostic microchips. The company was established to commercialize excellent research results and through that to advance public health and safety. The company portfolio includes several diagnostic prototypes, such as enhanced microarray substrates, cell culture surfaces and “smart” microfluidics. Nanoplasmas is presently using the infrastructure of the Institute of Nanoscience and Nanotechnology (INN) of NCSR Demokritos.